Post-earnings recap
Reported
Thu, Feb 21, 2019
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
63%
Dexcom's strong EPS performance indicates better-than-expected profitability, which likely contributed to the slight increase in stock price. However, the lack of revenue data and forward guidance may leave investors cautious. The stock's modest rise suggests that while investors are pleased with the EPS beat, they are awaiting more comprehensive financial details in future reports.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.54 | N/A | +185.70% |
| Revenue | N/A | N/A | N/A |
Overall, management conveyed a positive outlook on their earnings performance. They emphasized the importance of innovation and market expansion.
Management expressed satisfaction with the strong EPS performance.
They highlighted ongoing investments in product innovation.
There was a focus on expanding market reach despite competitive pressures.
—
Est. EPS
—
Est. Rev
—
Impl. Move
—